Inventor · disambiguated record
Seng H. Cheng
Also filed as: CHENG SENG · CHENG SENG H · CHENG SENG HING
71 granted patents·59 pending applications·1,907 citations·filing 1993–2025
99Inventor score
Top patents by PatentIndex Score
130 records- 0198US11911440B2Gene therapy for neurodegenerative disordersGENZYME CORP·Filed 2022·Granted Feb 27, 2024·5 cites·20 claims
- 0297US11975043B2Gene therapy for neurodegenerative disordersGENZYME CORP·Filed 2022·Granted May 7, 2024·3 cites·33 claims
- 0397US9717750B2Compositions and methods for modulation of SMN2 splicing in a subjectBIOGEN MA INC·Filed 2015·Granted Aug 1, 2017·26 cites·42 claims
- 0497US8980853B2Compositions and methods for modulation of SMN2 splicing in a subjectBENNETT C FRANK·Filed 2010·Granted Mar 17, 2015·48 cites·4 claims
- 0596US10369193B2Gene therapy for neurodegenerative disordersGENZYME CORP·Filed 2016·Granted Aug 6, 2019·17 cites·13 claims
- 0696US9765338B2Modulation of dystrophia myotonica-protein kinase (DMPK) expressionISIS PHARMACEUTICALS INC·Filed 2015·Granted Sep 19, 2017·67 cites·24 claims
- 0796US5948767ACationic amphiphile/DNA complexesGENZYME CORP·Filed 1996·Granted Sep 7, 1999·271 cites·13 claims
- 0895US9415119B2Gene therapy for neurodegenerative disordersGENZYME CORP·Filed 2015·Granted Aug 16, 2016·13 cites·7 claims
- 0995US9273315B2Modulation of huntingtin expressionISIS PHARMACEUTICALS INC·Filed 2014·Granted Mar 1, 2016·19 cites·14 claims
- 1094US10907142B2Oligosaccharides comprising an aminooxy group and conjugates thereofGENZYME CORP·Filed 2019·Granted Feb 2, 2021·4 cites·1 claims
- 1194US7910545B2Combination enzyme replacement and small molecule therapy for treatment of lysosomal storage diseasesGENZYME CORP·Filed 2007·Granted Mar 22, 2011·42 cites·3 claims
- 1294US7658916B2Methods of enhancing lysosomal storage disease therapy by modulation of cell surface receptor densityGENZYME CORP·Filed 2003·Granted Feb 9, 2010·43 cites·11 claims
- 1394US5783565ACationic amphiphiles containing spermine or spermidine cationic group for intracellular delivery of therapeutic moleculesGENZYME CORP·Filed 1996·Granted Jul 21, 1998·123 cites·4 claims
- 1494US5719131ACationic amphiphiles containing dialkylamine lipophilic groups for intracellular delivery of therapeutic moleculesGENZYME CORP·Filed 1995·Granted Feb 17, 1998·119 cites·24 claims
- 1593US10837016B2Modulation of huntingtin expressionIONIS PHARMACEUTICALS INC·Filed 2020·Granted Nov 17, 2020·2 cites·16 claims
- 1693US6066626ACompositions and method for treating lysosomal storage diseaseGENZYME CORP·Filed 1998·Granted May 23, 2000·154 cites·14 claims
- 1792US12350311B2Gene therapy for neurodegenerative disordersGENZYME CORP·Filed 2024·Granted Jul 8, 2025·0 cites·21 claims
- 1892US11253485B2Slow intraventricular deliveryGENZYME CORP·Filed 2019·Granted Feb 22, 2022·4 cites·15 claims
- 1992US11008316B2Glucosylceramide synthase inhibitorsGENZYME CORP·Filed 2017·Granted May 18, 2021·6 cites·2 claims
- 2092US9834604B2Inhibitors of T-cell activationZHU YUNXIANG·Filed 2012·Granted Dec 5, 2017·22 cites·13 claims
- 2192US8003617B2Methods of treating diabetes mellitusGENZYME CORP·Filed 2005·Granted Aug 23, 2011·27 cites·50 claims
- 2292US6071890AOrgan-specific targeting of cationic amphiphile/DNA complexes for gene therapyGENZYME CORP·Filed 1995·Granted Jun 6, 2000·128 cites·14 claims
- 2391US10821154B2Compositions and methods for treating spinal muscular atrophyGENZYME CORP·Filed 2013·Granted Nov 3, 2020·7 cites·19 claims
- 2491US10213494B2Treatment of synucleinopathiesBRIGHAM & WOMENS HOSPITAL INC·Filed 2016·Granted Feb 26, 2019·11 cites·8 claims
- 2591US8796236B2Gene therapy for lysosomal storage diseasesDODGE JAMES·Filed 2009·Granted Aug 5, 2014·12 cites·7 claims
- 2691US8716327B2Methods of treating fatty liver diseaseZHAO HONGMEI·Filed 2007·Granted May 6, 2014·44 cites·12 claims
- 2790US10619158B2Modulation of huntingtin expressionIONIS PHARMACEUTICALS INC·Filed 2019·Granted Apr 14, 2020·2 cites·16 claims
- 2890US8926967B2Intraventricular enzyme delivery for lysosomal storage diseasesDODGE JAMES·Filed 2008·Granted Jan 6, 2015·13 cites·29 claims
- 2990US8759501B2Oligosaccharides comprising an aminooxy group and conjugates thereofZHU YUNXIANG·Filed 2008·Granted Jun 24, 2014·10 cites·17 claims
- 3089US9683236B2Modulation of huntingtin expressionIONIS PHARMACEUTICALS INC·Filed 2016·Granted Jun 20, 2017·5 cites·16 claims
- 3189US8454954B2Treatment of synucleinopathiesSCHLOSSMACHER MICHAEL·Filed 2008·Granted Jun 4, 2013·20 cites·11 claims
- 3289US5935936ACompositions comprising cationic amphiphiles and co-lipids for intracellular delivery of therapeutic moleculesGENZYME CORP·Filed 1996·Granted Aug 10, 1999·85 cites·20 claims
- 3389US5650096ACationic amphiphiles for intracellular delivery of therapeutic moleculesGENZYME CORP·Filed 1994·Granted Jul 22, 1997·92 cites·7 claims
- 3489US2025263685A1Oligosaccharides comprising an aminooxy group and conjugates thereofGENZYME CORP·Filed 2024·Application pending·0 cites
- 3588US2024033323A1Gene Therapy For Neurodegenerative DisordersGENZYME CORP·Filed 2023·Application pending·0 cites
- 3688US2025288644A1Gene Therapy For Neurodegenerative DisordersGENZYME CORP·Filed 2025·Application pending·0 cites
- 3787US11421231B2Modulation of Huntington expressionIONIS PHARMACEUTICALS INC·Filed 2020·Granted Aug 23, 2022·1 cites·16 claims
- 3887US9469850B2Oligosaccharides comprising an aminooxy group and conjugates thereofGENZYME CORP·Filed 2014·Granted Oct 18, 2016·6 cites·12 claims
- 3987US2024238326A1Compositions and methods for modulation of smn2 splicing in a subjectBIOGEN MA INC·Filed 2023·Application pending·0 cites
- 4086US12060349B2Glucosylceramide synthase inhibitorsGENZYME CORP·Filed 2021·Granted Aug 13, 2024·1 cites·7 claims
- 4186US10080783B2Intraventricular enzyme delivery for lysosomal storage diseasesGENZYME CORP·Filed 2014·Granted Sep 25, 2018·6 cites·22 claims
- 4286US8912177B2Method of treating polycystic kidney diseases with ceramide derivativesNATOLI THOMAS A·Filed 2008·Granted Dec 16, 2014·8 cites·13 claims
- 4385US10744210B2Gene therapy for spinal cord disordersDODGE JAMES·Filed 2007·Granted Aug 18, 2020·8 cites·10 claims
- 4485US8906873B2Modulation of huntingtin expressionHUNG GENE·Filed 2010·Granted Dec 9, 2014·8 cites·8 claims
- 4584US10626169B2Multispecific binding molecules having specificity to dystroglycan and laminin-2SANOFI SA·Filed 2018·Granted Apr 21, 2020·8 cites·17 claims
- 4684US10202603B2Modulation of huntingtin expressionIONIS PHARMACEUTICALS INC·Filed 2017·Granted Feb 12, 2019·2 cites·16 claims
- 4784US2025002578A1Inhibitors of t-cell activationGENZYME CORP·Filed 2024·Application pending·0 cites
- 4883US9532976B2Method of lowering blood glucoseGENZYME CORP·Filed 2014·Granted Jan 3, 2017·5 cites·33 claims
- 4982US12297431B2Modulation of huntingtin expressionIONIS PHARMACEUTICALS INC·Filed 2022·Granted May 13, 2025·0 cites·14 claims
- 5082US2025026749A1Glucosylceramide synthase inhibitorsGENZYME CORP·Filed 2024·Application pending·0 cites
Showing the top 50 of 130 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →